Gene fusion is among the primary processes that generate new genes and has been well characterized as potent pathway of oncogenesis. Here, by high-throughput RNA sequencing in nine paired human endometrial carcinoma (EC) and matched non-cancerous tissues, we obtained that chimeric translin-associated factor X-disrupted-in-schizophrenia 1 (TSNAX-DISC1) occurred significantly upregulated in multiple EC samples. Experimental investigation showed that TSNAX-DISC1 appears to be formed by splicing without chromosomal rearrangement. The chimera expression inversely correlated with the binding of CCCTC-binding factor (CTCF) to the insulators. Subsequent investigations indicate that long intergenic non-coding RNA lincRNA-NR_034037, separating TSNAX from DISC1, regulates TSNAX-DISC1 production and TSNAX/DISC1 expression levels by extricating CTCF from insulators. Dysregulation of TSNAX influences steroidogenic factor-1-stimulated transcription on the StAR promoter, altering progesterone actions, implying the association with cancer. Together, these results advance our understanding of the mechanism in which lincRNA-NR_034037 regulates TSNAX-DISC1 formation programs that tightly regulate EC development.
Introduction
Endometrial carcinoma (EC) is one of the most common gynecologic malignancies and has significantly increased in both incidence and mortality over the past decade (1) . Risk factors include early/late age at menarche, obesity, use of tamoxifen and estrogen-alone hormone-replacement therapy positively associated with EC (2, 3) . However, only a small proportion of exposed individuals develop EC, suggesting that genetic factors, such as genetic abnormalities may contribute to EC risk (4, 5) .
Over the past few years, an important breakthrough in the search for novel pathogenesis of cancer was reported by using RNA sequencing (RNA-Seq) to comprehensively elucidate gene fusion products in cancer transcriptomes (6, 7) . Often, as a prevalent class of mutations, fusion genes are forming from two separated genes and can generate new transcripts that could serve as novel clinical biomarkers for diagnosis and therapeutic targets in cancer. Fusion transcripts often occurred as a result of chromosomal rearrangement. The other mechanism by which a chimera product can be generated is trans-splicing, appearing between the separate pre-mRNA.
CYCLIN D1-TROP2 chimera is generated through the intermolecular splicing between independently transcribed CYCLIN D1 and TROP2 mRNAs and was shown to be a potent oncogene in human cancers (8) . The two possible mechanisms in the formation of chimeras contribute to their biological significance. Potential regulatory role of chimeric transcripts have been showed in cancer cell growth (9) . Moreover, a subset of these chimeras have also been observed to be aberrantly expressed and lead to dysfunction of protein by deregulation of RNA processing in cancers, implying their associations within human tumor development (6, 10) .
Chimeric translin-associated factor X-disrupted-in-schizophrenia 1 (TSNAX-DISC1) is located on chromosome 1q42.2, a strongest genetic susceptibility locus for EC among Asian (11) . TSNAX-DISC1 contains all but the last two exons of TSNAX followed by all but the first exon of DISC1, which are normally the sites of termination and initiation of transcription, respectively. DISC1, originally identified as a risk factor for major mental illness, has a crucial role in maintenance of mental health and neuronal development (12, 13) . TRAX encoded by TSNAX could interact with Translin as the nucleic acid-binding complex. TRAX/Translin, which binds to DNA and RNA in vivo and thus has potential functions in cell growth regulation (14, 15) , genome stability regulation (16) , DNA damage recovery (17, 18) and carcinogenesis (19, 20) . Additionally, studies by Mellon et al. have shown that TRAX work together with Translin to coactivate the transcription factor steroidogenic factor-1 (SF-1)-stimulated transcription in HeLa cells (21) . SF-1 as a critical regulator of the expression of human steroidogenic genes (StAR) can regulate StAR transcription by activating the promoter of StAR in EC (22) . Importantly, the dysregulation of StAR would alter progesterone biosynthesis, metabolism and actions, which might be implied in the development of EC (23) . Previous studies have indicated that production of the chimeric TSNAX-DISC1 results from intergenic splicing between TSNAX and DISC1 (24) , however, the precise mechanism regulating the chimera formation and its function in cancers is yet to be thoroughly elucidated.
Intriguingly, a long intergenic non-coding RNA lincRNA-NR_034037 transcribed from opposite strand of the same region of chromosome 1 separates TSNAX from the downstream DISC1. Additionally, a high density of CCCTC-binding factor (CTCF) sites were found bound to the intergenic regions between TSNAX and DISC1. As one of the bestcharacterized 11 zinc finger proteins, CTCF's role has been identified as the major protein implicated in establishment of insulators in vertebrates (25, 26) . Given the positional effect of lincRNA-NR_034037 and majorities of CTCF-binding sites in intergenic regions, we hypothesis that lincRNA-NR_034037 may modulate intergenic splicing of adjacent genes TSNAX and DISC1 by strongly inhibiting the insulator action of CTCF and could be sufficient to generate chimeric TSNAX-DISC1.
Here, we identified chimeric TSNAX-DISC1 in nine paired human EC and matched non-cancerous tissues using RNA-Seq and the expression of the chimera was further validated in EC and matched non-cancerous tissues using quantitative real-time PCR (qRT-PCR). To further study the mechanism of chimeric TSNAX-DISC1 formation, we conducted reverse transcription PCR (RT-PCR) of DNA analysis to further rule out the possibility of DNA rearrangement, followed by examining the correlation between the expression of lincRNA-NR_034037, the binding of CTCF to the gene boundary region and the level of chimeric TSNAX-DISC1.
Materials and methods

Study subjects
Nine paired human EC and matched non-cancerous tissues for RNASeq were obtained from the affiliate hospitals of Soochow University Abbreviations: CCK-8, Cell Counting Kit-8; ChIP, chromatin immunoprecipitation; CTCF, CCCTC-binding factor; DISC1, disrupted-in-schizophrenia 1; EC, endometrial carcinoma; EMSA, electrophoretic mobility shift assay; lincRNA, long intergenic non-coding RNA; LMD, Laser Microdissection; qRT-PCR, quantitative real-time PCR; RIP, RNA immunoprecipitation; RNASeq, RNA sequencing; RT-PCR, reverse transcription PCR; SF-1, steroidogenic factor-1; shRNA, short-hairpin RNA; siRNA, small interfering RNA; TSNAX, translin-associated factor X. † These authors contributed equally to this work.
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(Suzhou, China). To validate RNA expression data, we studied 176 paired EC tissues and matched non-cancerous tissues derived from eastern and southern Chinese populations. All subjects in the current study were ethnically homogenous Han Chinese. At recruitment, informed consent was obtained from each patient. The clinical characteristics of all patients are listed in Table I (see Supplementary Materials and methods, available at Carcinogenesis Online).
RNA-Seq and chimeric transcripts detection
RNAs extracted from EC samples were processed for 100-nucleotide paired-end transcriptome sequencing using the Illumina mRNA-Seq protocol (Illumina) (see Supplementary Materials and methods, available at Carcinogenesis Online). Transcript assembly and expression level quantification by RNA-Seq were calculated by fragments per kilobase of transcript per million mapped reads (FPKM) as proposed by Trapnell et al. (27) . RNASeq sequencing data have been deposited into the Gene Expression Omnibus (accession number GSE56087). 
Validation of fusion gene expression and qRT-PCR
Preparation of the cancer cell population by Laser Microdissection
All EC samples were cut from the resected endometrium and embedded in Tissue Tek OCT medium (Sakura, Tokyo, Japan). The detail preparation of the cancer cell population were obtained using the Laser Microdissection (LMD) system (Leica Laser Microdissection System, Leica Microsystems, Solms, Germany) as described previously (28) .
Subcellular fractionation
EC cell lines, namely, HEC-1-A and HEC-1-B were cultured in a humidified incubator for 2 days. For subcellular fractionation experiments, cytosolic and nuclear extracts from EC cells were collected using a Nuclear/Cytosol Fractionation kit (Biovision).
Lentiviral production and transduction
The cDNA sequence of lincRNA-NR_034037 and TSNAX-DISC1 were synthesized by the Genewiz Company (Suzhou, China) and then cloned into the lentiviral expression vector pLVX-IRES-neo (Clontech Laboratories, San Francisco, CA), respectively. The short-hairpin RNA (shRNA) against lincRNA-NR_034037 and TSNAX-DISC1 lentiviral expression vector was provided by GenePharma (Shanghai, China). Lentiviral production, and transduction were conducted by following previously published procedures (29) . For details, see Supplementary Materials and methods, available at Carcinogenesis Online.
Transient transfections and reporter gene assay
The binding motif regulated by SF-1 have been previously identified in the StAR gene (22) . The human -835bp DNA fragment was transfected into indicated stable EC cells with lincRNA-NR_034037 overexpression and knockdown (HEC-1-A-control, HEC-1-A-lincRNA-NR_034037, HEC-1-A-lincRNA-NR_034037-shRNA, HEC-1-B-control, HEC-1-B-lincRNA-NR_034037 and HEC-1-B-lincRNA-NR_034037-shRNA) with 2.25 μg of promoter constructs with or without 20 pmol Translin or SF-1 siRNA as described previously (22) . In lincRNA-NR_034037 promoter reporter assay, all the constructs (containing -965/-827 fragment) of the lincRNA promoter containing possible transcript factors binding sites were co-transfected with or without siRNA against Sox5 into HEC-1-A and HEC1-1-B cells. After transfection for 24 h, luciferase activity was measured with a dual luciferase reporter assay system (Promega, Madison, WI).
Western blotting and immunocytochemistry
Western blot analysis was performed as described previously (30) . Antibodies recognizing TRAX, DISC1 and StAR were from Santa Cruz. Antibodies recognizing CTCF and SF-1 were from Cell Signaling and Abcam. Immunofluorescence analysis of DISC1 and TRAX were performed using the Immunofluorescence Staining Kit (Beyotime Institute of Biotechnology, China) according to the manufacturer's instructions.
DNA and RNA electrophoretic mobility shift assay Synthetic 5′ biotin-labeled oligonucleotides and EC cell nuclear extracts were carried out by using the LightShift Chemiluminescent EMSA Kit (Pierce, Rockford, IL). For DNA electrophoretic mobility shift assay (EMSA), 4 μg 
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nuclear extract was incubated with 20 fmol labeled probe in each gel shift reaction (20 µl) for 20 min at room temperature before analysis by polyacrylamide gel electrophoresis. RNA EMSA was performed as described previously (31, 32) . Briefly, reactions were assembled as described above for DNA EMSA, except 125 nmol biotin-labeled RNA probe was replaced with the double-stranded DNA probes. The DNA/RNA-protein complexes were resolved and detected using chemiluminescence reagent (Pierce). For RNA-DNA titration experiments, RNA competitor (lincRNA-NR_034037 RNA probe) (595 nt) was in vitro transcribed with T7 RNA polymerase (Invitrogen) off PCR-amplified cDNA template created using primers 5′-TAATACGACTCACTATAGGCTTCACACCTTGGGTCAG-3′(T7-F), 5′-GGGAATTTGTACTTTTCTGCA-3′(R) according to the according to standard protocols. Sequences of synthesized DNA and RNA probes are described in Supplementary 
Cell cycle analysis
For cell cycle analysis, indicated stable EC cells were plated at a concentration of 1 × 10 6 per 10 cm dish and permeabilized with 70% ethanol overnight at 4°C. DNA was stained with 0.5 ml propidium iodide staining solution and cellular DNA content was analyzed by flow cytometry (FACScalibur; BD Biosciences).
Cell viability assay
In 96-well, flat-bottomed plates (BD Biosciences, Bedford, MA), 100 μl stable EC cells suspension (10 000 cells per ml) was aliquoted into each well. Cell viability was measured by Cell Counting Kit-8 (CCK-8) (Dojindo Laboratory, Kumamoto, Japan) based on the manufacturer's instructions.
Colony formation assay
The stable EC cells (200 cells) were seeded in a 60 mm plate, respectively. After incubation for 2 weeks at 37°C in 5% humidified CO 2, colonies (>50 cells per colony) were counted after staining with Giemsa and photographed. 
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Xenograft model in nude mice
The stable EC cells were diluted to a concentration of 1 × 10 6 cells/ml in physiological saline, and 0.1 ml of the suspension was injected subcutaneously into the posterior flank of mice (8 mice/group). When a tumor was palpable, tumor growth was measured every other day with calipers, and tumor volume was calculated according to the following formula: V = L × W 2 × 0.5 (L, length; W, width).
Statistical analysis
Statistical analyses were conducted by Fisher's exact tests or two-tailed Student's t-test as indicated. One-way analysis of variance test and linear regression models were used to identify the effect of lincRNA-NR_034037 expression on the TSNAX-DISC1 mRNA level in EC cells and the expression correlation between TSNAX-DISC1 and lincRNA-NR_034037 in EC tissues. All these statistical analyses were performed using SPSS (Version 17.0, SPSS). All P values were two-sided. A P value of <0.05 was considered statistically significant.
Results
Identification of chimeric TSNAX-DISC1 in EC
To identify chimeric RNAs that are expressed in EC, we sequenced the transcriptome of 9 pairs of human EC and matched non-cancerous tissues. Based on standardized RNA-Seq analysis procedure, we identified chimeric TSNAX-DISC1, which is located on EC susceptibility locus 1q42.2 associated with EC risk by genome-wide association study (11) . TSNAX-DISC1 contains all but the last two exons of TSNAX followed by all but the first exon of DISC1. One annotated exon and at least two previously unannotated exons situated in the chimeria naturally result in read-through transcription ( Figure 1A ). RT-PCR and Sanger sequencing was performed to identify the fusion junction ( Figure 1B ). Analysis of paired chimeric reads showed that chimeric TSNAX-DISC1 occurred significantly unregulated in EC (P < 0.05) (Supplementary Figure 1A , available at Carcinogenesis Online), suggesting that the chimera RNA is frequently amplified in human EC.
Verification and aberrant expression of chimeric TSNAX-DISC1 in EC
We designed specific primers to validate the presence of TSNAX-DISC1 in 104 paired EC tissues and matched non-cancerous tissues from Suzhou cohort, as well as in 72 paired EC tissues and matched non-cancerous tissues from Guangzhou cohort. Chimeric TSNAX-DISC1 was expressed at a higher level in ~71.2% (74/104 patients in the Suzhou cohort) and 68.1% (49/72 patients in the Guangzhou cohort) of the EC tissues ( Figure 1C ). We further examined whether TSNAX-DISC1 expression level correlated with clinicopathological characteristics of EC. According to the previous study (33) , the 176 EC patients were classified into two groups: relative high-TSNAX-DISC1 group (N = 88, TSNAX-DISC1 expression ratio ≥ the median ratio of relative TSNAX-DISC1 expression (0.33) in EC tissues and relative low-TSNAX-DISC1 group (N = 88, TSNAX-DISC1 expression ratio ≤ 0.33). However, TSNAX-DISC1 expressions in EC were not associated with any clinical factor, as showed in Supplementary Table 2 , available at Carcinogenesis Online. We further evaluated the expression of chimeric TSNAX-DISC1 and its parental genes in 36 paired EC and matched non-cancerous samples from Suzhou. The result showed that TSNAX and DISC1 in ~86% (31/36) and 78% (28/36) of non-cancerous tissues were significantly overexpressed ( Figure 1D ). Additionally, patients with higher TSNAX-DISC1 expression levels in EC tissues showed substantial down-regulation of TRAX and DISC1; TSNAX-DISC1 expression was moderately inversely correlated with levels of TRAX and DISC1 ( Figure 1E , R = 0.379, P = 0.023 for TRAX; R = 0.343, P = 0.041 for DISC1). Furthermore, to disprove the heterogeneity of tumor samples, we quantified the chimeric TSNAX-DISC1 expression in the enrolled 15 EC tissues LMD-measured and non-LMD-measured samples by RT-PCR. The results showed that there was no significant difference between LMD-measured and non-LMD-measured samples of both EC and corresponding adjacent normal tissues (Supplementary Figure 1B , available at Carcinogenesis Online).
Mechanism of genomic DNA rearrangement responsible for chimeric TSNAX-DISC1 formation
To verify whether genomic DNA rearrangements might be responsible for the chimeric TSNAX-DISC1 formation, we performed specific RT-PCR to evaluate the expression of TSNAX-DISC1 with EC tissues and EC cell lines at genomic DNA level and transcriptional level. The expected PCR size from cDNA and absence of size from genomic DNA for chimeric TSNAX-DISC1 indicated that the chimera was produced by RNA processing read-through without DNA-level rearrangement (Figure 2A) .
CTCF binds these insulators and correlates with TSNAX-DISC1 repression
Insulator's function in gene regulation is mainly associated with CTCF by recognizing long and diverse nucleotide sequences. Three potential insulator sequences existing in the intergenic region between TSNAX and DISC1 genes have been identified by genome-wide mapping of CTCF-binding sites (34) . We used various primers to amplify transcripts on TSNAX, DISC1 and intergenic regions between these two genes and detected intergenic transcripts with primer pairs 3, 4 and 5 that similar to the chimeric TSNAX-DISC1 ( Figure 2B ).
We identified three putative CTCF-binding sites in insulator 1, insulator 2 and insulator 3 located in intergenic regions between TSNAX and DISC1 genes by the CTCF-binding site database. We asked if CTCF directly binds the three insulators by performing EMSA. As showed in Figure 2C , strong binding shifts (lanes 2 and 5) was found using biotin-labeled DNA probes for corresponding to insulator 1, insulator 2 and insulator 3 sequences containing CTCF binding sites. Additionally, the result of ChIP-qPCR showed that CTCF occupied these three insulators ( Figure 2D ), consistent with EMSA results.
Three different small interfering RNAs (siRNAs; designated as siRNA-1, siRNA-2 and siRNA-3) against CTCF was used to evaluate the effect of CTCF on TSNAX-DISC1 expression in EC cells. Effective silencing of CTCF siRNA-1 and siRNA-2 were presented in Supplementary Figure 2A , available at Carcinogenesis Online. We utilized siRNA-3 against CTCF for significant reduction in CTCF expression to perform the subsequent investments. As expected, the increase of chimeric TSNAX-DISC1 and the concomitant reduction of TSNAX/DISC1 transcripts by CTCF siRNA-3 in EC cells ( Figure 2E ), is consistent with the hypothesis that the binding of CTCF to insulators prevents basal levels of transcription through the boundary of the TSNAX and DISC1 genes.
CTCF binds to lincRNA-NR_034037
LincRNA-NR_034037 was moderately more abundant in HEC-1-A and HEC-1-B nucleus, respectively (Supplementary Figure 2B , available at Carcinogenesis Online), suggesting an essential role of lncRNA in the nuclear function. Moreover, we detected three CTCF-binding sites within the non-coding RNA (Supplementary Figure 2C , available at Carcinogenesis Online). We asked if lincRNA-NR_034037 RNA and CTCF interact by EMSA. Significant RNA-protein complex binding shift were detectable ( Figure 2F, lanes 2 and 5) , using biotinlabeled RNA probes (1, 2 and 3) for lincRNA-NR_034037 containing CTCF binding sites. However, no specific RNA-protein complex (Supplementary Figure 2D , available at Carcinogenesis Online, lanes 1 and 3) was found for the mutated lincRNA-NR_034037 RNA probes lacking CTCF binding sites. Furthermore, RIP experiments with an antibody against CTCF showed a significant enrichment of lincRNA-NR_034037 with the CTCF antibody, compared with the non-specific IgG control antibody ( Figure 2G ). Together, these data suggested that lincRNA-NR_034037 directly interacts with CTCF. Online, R = 0.453, P = 0.005) in 36 EC samples from Suzhou. We then analyzed TSNAX-DISC1 and lincRNA-NR_034037 expression levels in indicated stable EC cell lines by qRT-PCR. Intriguingly, overexpression of lincRNA-NR_034037 in stable EC cell lines showed concomitant high levels of TSNAX-DISC1 ( Figure 2H ). Inversely, we observed down-regulation of TRAX and DISC1 levels ( Figure 2I ). In addition, we used three shRNAs against lincRNA-NR_034037 (shRNA-1, shRNA-2 and shRNA-3) to construct lincRNA-NR_034037-downregulated cells. Because of their effectiveness, we utilized lincRNA-NR_034037-shRNA-1 transfected cells as lincRNA-NR_034037 down-regulated cells. The effectiveness of two other shRNAs against lincRNA-NR_034037 in cells was examined (Supplementary Figure 2F , available at Carcinogenesis Online). Levels of TSNAX-DISC1 were reduced and levels of TRAX and DISC1 were increased with knockdown of lincRNA-NR_034037-shRNA-1 ( Figure 2H and I) . Expression of TRAX and DISC1 were analyzed by immunocytochemical analysis and similarly, high levels of TRAX and DISC1 were seen in the nucleus and cytoplasm of HEC-1-A cells with lincRNA-NR_034037 knockdown, respectively, whereas levels of both were considerably reduced with lincRNA-NR_034037 overexpression ( Figure 2J ). The same result was also observed in HEC-1-B cells (Supplementary Figure 3 , available at Carcinogenesis Online).
LincRNA-NR_034037 facilitates the production of TSNAX-DISC1 by evicting CTCF
Given the fact of physical interaction and the concomitant levels of TSNAX-DISC1 and lincRNA-NR_034037 ( Figure 2H ), we raised the possibility that the production of chimeric TSNAX-DISC is regulated by lincRNA-NR_034037 through titrating CTCF binding from these insulators. Interestingly, in the reciprocal DNA EMSA, the insulators-CTCF shift was progressively titrated away by increasing amounts of lincRNA-NR_034037 ( Figure 2C, lanes 3 and 6) .
Translin/TRAX cooperates with SF-1 on the human StAR promoter and activates StAR in EC Cells
Previous GST pull-down and luciferase reporter assays have showed that Translin and TRAX likely form heteromers and bind to SF-1 to augment SF-1-dependent transcriptional activation (21) (Figure 3A) . Additionally, HEC-1-A cells have been shown to express SF-1 and StAR (22) . We assessed protein levels of SF-1 and StAR in EC cells by western blot. SF-1 and StAR were found to be present in EC lines as shown in Figure 3B . Then, we tested whether SF-1 and StAR levels are influenced by TRAX in lincRNA-NR_034037 or lincRNA-NR_034037-shRNA-transfected EC cells with TRAX down-regulation or overexpression. The results showed that StAR is strongly up-regulated in response to TRAX overexpression in lincRNA-NR_034037-shRNA-transfected EC cells, whereas SF-1 levels were unaffected ( Figure 3C ). Additionally, StAR expression correlated with TSNAX-DISC1 in EC tissues (R = 0.350, P = 0.037) ( Figure 3D Supplementary  Figure 4 , available at Carcinogenesis Online. Consist with previous study showing that TRAX could work together with Translin to coactivate SF-1-stimulated transcription (21) , the result showed that TRAX overexpression in HEC-1-A cells transfected with a luciferase reporter construct in the presence of SF-1 and Translin significantly affected SF-1 stimulated transcription, whereas TRAX had only a slight effect on transcription from the luciferase reporter construct in the absence of Translin ( Figure 3E ). When SF-1 was absent, TRAX had no effect on the StAR promoter. Thus, TRAX appears to function together with Translin to activate SF-1-stimulated transcription. Similar results were observed in HEC-1-B cells. Furthermore, ChIP assay indicated differential binding of TRAX to the StAR promoter in EC cell lines in the absence or presence of SF-1 and Translin. As shown in Figure 3F , a remarkable enrichment of TRAX was observed in the StAR promoter; however, TRAX binding activity was either minimal or non-existent in EC cells in the absence of SF-1 or Translin.
Sox5-binding site contributes to the lincRNA-NR_034037 transcription
The fact that lincRNA-NR_034037 regulates TSNAX-DISC1 formation programs prompts us to evaluate transcriptional regulators, potential role of the cis-elements at the lincRNA-NR_034037 promoter region. We scanned the lincRNA promoter with the bioinformatics software (http://www.fruitfly.org/seq_tools/promoter.html, http://mbs.cbrc.jp/research/db/TFSEARCH.html), three putative transcript factors (CDX1, Sox5, CP2) binding sites was predicted within -965/-827 region. To confirm the roles of these three sites in transcription activity of the lincRNA-NR_034037, deletion of any one of these three sites was tested for promoter function in the EC cell lines. The results showed that when the Sox5 binding site is deleted, promoter activities were reduced to background levels, however, no promoter activity change was found when either CDX1 or CP2 binding sites was deleted ( Figure 4A ). The endogenous Sox5 expression level in HEC-1-A cells was similar with that of HEC-1-B cells (Supplementary Figure 5A , available at Carcinogenesis Online) and effective silencing of Sox5 expression in EC cells after transfection with Sox5 siRNAs were presented in Supplementary Figure 5B , available at Carcinogenesis Online. Moreover, knockdown studies were performed to further test the role of Sox5 in regulating lincRNA-NR_034037 promoter activation. To address this, we inhibited Sox5 expression using siRNA. The siRNA resulted in inhibition of both promoter activation and expression levels of lincRNA-NR_034037 ( Figure 4B and C) . These results demonstrate that the Sox5 binding site is necessary for transcriptional initiation and drives lincRNA-NR_034037 expression in EC cells.
Effect of lincRNA-NR_034037 on cell cycle dynamics in EC Cells
We further evaluated the effects of lincRNA-NR_034037 on cell cycle phase distribution using the indicated stable EC cells by flow cytometry (FACS) analysis. As shown in Figure 5A , overexpression of lincRNA-NR_034037 resulted in a statistically significant accumulation of EC cells in S phase (HEC-1-A cells: 6.1% increase, P = 0.033; HEC-1-B cells: 5.3% increase, P = 0.038) accompanied by a decrease in G 1 cells (HEC-1-A cells: 7.0% decrease, P = 0.021; HEC-1-B cells: 8.7% decrease, P = 0.009), compared with controls. In contrast, there was a noteworthy decrease in cells in S phase with lincRNA-NR_034037-downregulation (HEC-1-A cells: 7.9% decrease, P = 0.001; HEC-1-B cells: 5.5% decrease, P = 0.028) accompanied by an increase in G 1 cells (HEC-1-A cells: 6.9% increase, P = 0.012; HEC-1-B cells: 9.0% increase, P = 0.009), compared with the controls. 
Discussion
This study provides a novel survey of chimeric transcripts expressed in EC. We found chimeric TSNAX-DISC1 dramatically up-regulated activity in EC cells. Indicated stable EC cells were co-transfected with promoter constructs with or without Translin or SF-1 siRNA. Renilla luciferase activity was measured and normalized to firefly luciferase. Six replicates were carried out for each group, and the experiment was repeated three times. Data are mean ± SEM. *P < 0.05 compared with negative control. in EC tissues using RNA-Seq. Our data argued that a cluster of CTCF binding sites situated in insulator elements between TSNAX and DISC1 functioned to regulate TSNAX and DISC1 genes expression. Moreover, lincRNA-NR_034037, interacting with Sox5 through its binding site in the lincRNA promoter up-regulates the expression of lincRNA-NR_034037. We showed that lincRNA-NR_034037, which is complementary to intergenic sequence apart TSNAX and DISC1 may titrate away CTCF from insulator elements by competing for binding to CTCF, by doing so, induce the generation of chimeric transcript. In addition, high levels of TSNAX-DISC1 in EC cells with stable overexpression of lincRNA-NR_034037 were able to induce G 1 -S cell cycle progression and enhance cell growth, both in vitro and in vivo. These results point toward the molecular mechanisms of TSNAX-DISC1 formation and its correlation with EC development.
The chimeric TSNAX-DISC1 represents naturally occurring readthrough transcription between the neighboring genes TSNAX and DISC1 on chromosome 1q42.2, a region in which a susceptibility locus for EC has been identified (11), indicating a potential role of TSNAX-DISC1 in the cancer paradigm. DISC1, a candidate gene for schizophrenia, has recently been shown to be involved in behavioral disorders, maintenance of mental health and other functions in neural progenitor proliferation and migration. Moreover, computational identification methods and ChIP-chop analysis also support a link between the neural gene DISC1 and cancer progression (35, 36) . In addition, the TSNAX gene, which is located immediately upstream of DISC1, has been intensively studied. TSNAX, which encodes TRAX, aggregates into insoluble complexes when expressed alone and has no measurable independent nucleic-acid-binding capability (37) , but forms a stable heteromeric complex exhibiting important biological functions upon co-expression with Translin. An early study from the Mellon group identified an intimate link between the Translin/TRAX complex and transcription, in that TRAX and Translin form heteropolymers in vivo which potentiates their ability to activate SF-1-stimulated transcription (38) . Furthermore, a handful of studies have also implicated TRAX and Translin in maintenance of genome integrity and the cell growth process, particularly in response to DNA damage recovery (16, 19, 39, 40) . Despite evidence that the TSNAX-DISC1 fusion transcript results from intergenic splicing of two neighboring genes, TSNAX and DISC1, key questions regarding the mechanisms underlying the formation of the chimeric transcript remains elusive.
By clarifying the genomic position of TSNAX-DISC1, we identified a cluster of known CTCF-binding sites situated in insulators between TSNAX and DISC1. A number of investigations have examined CTCF's function as a major factor implicated in vertebrate insulator activities (41) (42) (43) . Consistent with this model, our study showed that CTCF bound these insulators between TSNAX and DISC1, and correlated with TSNAX-DISC1 repression. Bioinformatics analysis showed that lincRNA-NR_034037 transcribed from the opposite strand in the same region of chromosome one and a high density distribution of CTCF-binding sites fallen within the non-coding RNA. Our subcellular fractionation assay showed that lincRNA-NR_034037 was widely expressed in the nucleus of fractionated EC cells, suggesting the function of this lncRNA in the nucleus. REMSA showed that significant RNA-protein complex binding shift were observed using biotin-labeled RNA probes for lincRNA-NR_034037 containing CTCF binding sites. RIP experiments with an antibody against CTCF further validated the association between lincRNA-NR_034037 and CTCF. Importantly, our results revealed that expression of lincRNA-NR_034037 positively correlated with the expression of TSNAX-DISC1. The physical interaction and the concomitant levels of TSNAX-DISC1 and lincRNA-NR_034037 raised the possibility that the production of chimeric TSNAX-DISC1 was regulated by lincRNA-NR_034037 through titrating CTCF binding from these insulators. Similarly, in the reciprocal DNA EMSA, the insulators-CTCF shift was progressively titrated away by increasing amounts of lincRNA-NR_034037. The result revealed that lincRNA-NR_034037 and insulator elements may compete for binding to CTCF, and the competitive interactions regulate chimeric TSNAX-DISC1 production and TSNAX/DISC1 expression levels. Our luciferase reporter assay and ChIP data demonstrated that dysregulation of TRAX influences SF-1-stimulated transcription on the StAR promoter, which altered progesterone actions and may be implicated in the development of EC.
To date, in addition to the well-established mechanism by which a fusion transcript can be generated by chromosomal rearrangement, the chimeric transcript unrelated to chromosomal rearrangements often occurs by transcription-induced chimeras. A previous example of post-transcriptional event, chimeric JAZF1-JJAZ1 is likely resulting from trans-splicing of exons between precursor mRNAs for the JAZF1 and JJAZ1 genes (44) . The generation of noncanonical transsplicing chimeric CYCLIN D1-TROP2 in the absence of chromosomal rearrangements showed a novel oncogenic mechanism, which seems to be widespread in human cancers (8) . However, the specific mechanism of post-transcriptional chimera generating is as yet not known. Recently, as a regulator of transcriptional and epigenetic gene regulation, lncRNAs also possess the potential to influence major posttranscriptional processes of precursor mRNA splicing (45) (46) (47) . These lines of evidence, along with our results make it very likely that unregulated lincRNA-NR_034037 through the specific interaction of Sox5 with the lincRNA promoter may account for the conformation of TSNAX-DISC1 and, in turn suppression of the expression levels of TRAX and DISC1, and further induce cell cycle progression from G 1 to S phase and cell growth (Supplementary Figure 7 , available at Carcinogenesis Online).
In summary, our present study indicates that the chimeria TSNAX-DISC1 formation regulated by lincRNA-NR_034037 plays a key role in contributing to progression of EC. We suggest that TSNAX-DISC1 may be a potential candidate for a new genetic and epigenetic marker in EC.
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